Multiplex bead assay for serum samples from children in Haiti enrolled in a drug study for the treatment of lymphatic filariasis

American Journal of Tropical Medicine and Hygiene

Volumn 85, Issue 2, 2011, Pages 229-237

  Moss, Delynn M ^a   Priest, Jeffrey W ^a   Boyd, Alexis ^b   Weinkopff, Tiffany ^c   Kucerova, Zuzana ^c   Beach, Michael J ^a   Lammie, Patrick J ^c  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; CARBOXYLATED POLYSTYRENE MICROSPHERE; DIETHYLCARBAMAZINE; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; MEROZOITE SURFACE PROTEIN 1; MICROSPHERE; PLACEBO; PROTEIN; RECOMBINANT ANTIGEN; RECOMBINANT ANTIGEN BM14; RECOMBINANT ANTIGEN BM33; THIRD POLAR TUBE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BRUGIA MALAYI; CHILD; CONTROLLED STUDY; ENCEPHALITOZOON CUNICULI; FEMALE; HAITI; HUMAN; LYMPHATIC FILARIASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLEX BEAD ASSAY; NONHUMAN; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; SCHISTOSOMA JAPONICUM; SCHOOL CHILD; SEROLOGY; SINGLE DRUG DOSE;

ANTHELMINTICS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; CHILD; CHILD, PRESCHOOL; DIETHYLCARBAMAZINE; ELEPHANTIASIS, FILARIAL; HAITI; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; IVERMECTIN;

BRUGIA MALAYI; ENCEPHALITOZOON CUNICULI; PLASMODIUM FALCIPARUM;

EID: 80051528877     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2011.11-0029     Document Type: Article

References (45)

1. Wagner B, Freer H, 2009. Development of a bead-based multiplex assay for simultaneous quantification of cytokines in horses. Vet Immunol Immunopathol 127: 242-248.
2. Sharma RK, Rogojina AT, Chalam KV, 2009. Multiplex immunoassay analysis of biomarkers in clinically accessible quantities of human aqueous humor. Mol Vis 15: 60-69.
3. Teles RP, Likhari V, Socransky SS, Haffajee AD, 2009. Salivary cytokine levels in subjects with chronic periodontitis and in periodontally healthy individuals: a cross-sectional study. J Periodontal Res 44: 411-417.
4. Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO, Templin MF, Pawlita M, 2005. Multiplex human papillomavirus serology based on in situ -purified glutathione S-transferase fusion proteins. Clin Chem 51: 1845-1853. (Pubitemid 41368175)
5. Wong SJ, Demarest VL, Boyle RH, Wang T, Ledizet M, Kar K, Kramer LD, Fikrig E, Koski RA, 2004. Detection of human anti-flavivirus antibodies with a West Nile virus recombinant antigen microsphere immunoassay. J Clin Microbiol 42: 65-72. (Pubitemid 38082700)
6. Lobashevsky AL, Manwaring JE, Travis MM, Nord BL, Higgins NG, Serov YA, Arnoff TS, Hommel-Berrey GA, Goggins WC, Taber TE, Carter CB Sr, Smith DS, Wozniak TC, O'Donnell JA, Turrentine MW, 2009. Effect of desensitization in solid organ transplant recipients depends on some cytokines genes polymorphism. Transpl Immunol 21: 169-178.
7. Khan IH, Krishnan VV, Ziman M, Janatpour K, Wun T, Luciw PA, Tuscano J, 2009. A comparison of multiplex suspension array large-panel kits for profiling cytokines and chemokines in rheumatoid arthritis patients. Cytometry B Clin Cytom 76: 159-168.
8. Kellar KL, Mahmutovic AJ, Bandyopadhyay K, 2006. Multiplexed microsphere-based flow cytometric immunoassays. Current Protocols in Cytometry Chapter 13: Unit13 1. New York: John Wiley.
9. Dondog B, Clifford GM, Vaccarella S, Waterboer T, Unurjargal D, Avirmed D, Enkhtuya S, Kommoss F, Wentzensen N, Snijders PJ, Meijer CJ, Franceschi S, Pawlita M, 2008. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study. Cancer Epidemiol Biomarkers Prev 17: 1731-1738.
10. Moss DM, Montgomery JM, Newland SV, Priest JW, Lammie PJ, 2004. Detection of Cryptosporidium antibodies in sera and oral fluids using multiplex bead assay. J Parasitol 90: 397-404. (Pubitemid 38621348)
11. Kellar KL, Kalwar RR, Dubois KA, Crouse D, Chafin WD, Kane BE, 2001. Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry 45: 27-36. (Pubitemid 32807921)
12. Michael E, Bundy DA, Grenfell BT, 1996. Reassessing the global prevalence and distribution of lymphatic filariasis. Parasitology 112: 409-428. (Pubitemid 26126021)
13. Ottesen EA, Duke BO, Karam M, Behbehani K, 1997. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 75: 491-503. (Pubitemid 28099975)
14. Wattal S, Dhariwal AC, Ralhan PK, Tripathi VC, Regu K, Kamal S, Lal S, 2007. Evaluation of Og4C3 antigen ELISA as a tool for detection of bancroftian filariasis under lymphatic filariasis elimination programme. J Commun Dis 39: 75-84.
15. Liang JL, King JD, Ichimori K, Handzel T, Pa'au M, Lammie PJ, 2008. Impact of five annual rounds of mass drug administration with diethylcarbamazine and albendazole on Wuchereria bancrofti infection in American Samoa. Am J Trop Med Hyg 78: 924-928. (Pubitemid 351967810)
16. Atmadja AK, Atkinson R, Sartono E, Partono F, Yazdanbakhsh M, Maizels RM, 1995. Differential decline in filaria-specific IgG1, IgG4, and IgE antibodies in Brugia malayi -infected patients after diethylcarbamazine chemotherapy. J Infect Dis 172: 1567-1572.
17. Rabello AL, Garcia MM, Pinto da Silva RA, Rocha RS, Katz N, 1997. Humoral immune responses in patients with acute Schistosoma mansoni infection who were followed up for two years after treatment. Clin Infect Dis 24: 304-308.
18. Muck AE, Pires ML, Lammie PJ, 2003. Influence of infection with non-filarial helminths on the specificity of serological assays for antifilarial immunoglobulin G4. Trans R Soc Trop Med Hyg 97: 88-90. (Pubitemid 36874053)
19. Lammie PJ Weil G, Noordin R, Kaliraj P, Steel C, Goodman D, Lakshmikanthan VB, Ottesen E, 2004. Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis: a multicenter trial. Filaria J 3: 9.
20. Fox LM, Furness BW, Haser JK, Desire D, Brissau JM, Milord MD, Lafontant J, Lammie PJ, Beach MJ, 2005. Tolerance and efficacy of combined diethylcarbamazine and albendazole for treatment of Wuchereria bancrofti and intestinal helminth infections in Haitian children. Am J Trop Med Hyg 73: 115-121. (Pubitemid 41278759)
21. Dissanayake S, Xu M, Nkenfou C, Piessens WF, 1993. Molecular cloning and serological characterization of a Brugia malayi pepsin inhibitor homolog. Mol Biochem Parasitol 62: 143-146.
22. Lucchi NW, Tongren JE, Jain V, Nagpal AC, Kauth CW, Woehlbier U, Bujard H, Dash AP, Singh N, Stiles JK, Udhayakumar V, 2008. Antibody responses to the merozoite surface protein-1 complex in cerebral malaria patients in India. Malar J 7: 121.
23. Kucerova Z, Priest JW, Delbac F, Visvesvara GS, Secor WE, 2006. Expression and serologic assessment of a recombinant polar tube protein from Encephalitozoon cuniculi (PTP3). J Eukaryot Microbiol 53 (Suppl 1): S70-S71. (Pubitemid 44813333)
24. Waterboer T, Sehr P, Pawlita M, 2006. Suppression of non-specific binding in serological Luminex assays. J Immunol Methods 309: 200-204. (Pubitemid 43190816)
25. Helmy H, Weil GJ, Ellethy AS, Ahmed ES, Setouhy ME, Ramzy RM, 2006. Bancroftian filariasis: effect of repeated treatment with diethylcarbamazine and albendazole on microfilaraemia, antigenaemia and antifilarial antibodies. Trans R Soc Trop Med Hyg 100: 656-662 (Pubitemid 44287681)
26. Tisch DJ, Bockarie MJ, Dimber Z, Kiniboro B, Tarongka N, Hazlett FE, Kastens W, Alpers MP, Kazura JW, 2008. Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation. Am J Trop Med Hyg 78: 289-293. (Pubitemid 351844566)
27. Ramzy RM, El Setouhy M, Helmy H, Ahmed ES, Abd Elaziz KM, Farid HA, Shannon WD, Weil GJ, 2006. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet 367: 992-999.
28. Weil GJ, Ramzy RM, El Setouhy M, Kandil AM, Ahmed ES, Faris R, 1999. A longitudinal study of Bancroftian filariasis in the Nile Delta of Egypt: baseline data and one-year follow-up. Am J Trop Med Hyg 61: 53-58. (Pubitemid 29344988)
29. Yamagata GR, Gershwin LJ, Wong MM, 1995. Diethylcarbamazine-induced Dirofilaria immitis larval death, as indicated by immunoglobulin E concentration, in dogs with concurrent Ancylostoma caninum infection. Am J Vet Res 56: 174-178.
30. Fujimaki Y, Sakamoto M, Shimada M, Kimura E, Aoki Y, 1989. Diethylcarbamazine: inhibitory effect on acetylcholinesterase of Dirofilaria immitis and Brugia pahangi. Southeast Asian J Trop Med Public Health 20: 179-182. (Pubitemid 20053500)
31. Grieve RB, Mika-Johnson M, Jacobson RH, Cypess RH, 1981. Enzyme-linked immunosorbent assay for measurement of antibody responses to Dirofilaria immitis in experimentally infected dogs. Am J Vet Res 42: 66-69.
32. Grover JK, Vats V, Uppal G, Yadav S, 2001. Anthelmintics: a review. Trop Gastroenterol 22: 180-189.
33. Klion AD, Ottesen EA, Nutman TB, 1994. Effectiveness of diethylcarbamazine in treating loiasis acquired by expatriate visitors to endemic regions: long-term follow-up. J Infect Dis 169: 604-610. (Pubitemid 24063004)
34. Winkler S, Paiha S, Winkler H, Graninger W, Marberger M, Steiner GE, 1996. Microfilarial clearance in loiasis involves elevation of Th1 and Th2 products and emergence of a specific pattern of T-cell populations. Parasite Immunol 18: 479-482. (Pubitemid 26302822)
35. Scott AL, Ghedin E, 2009. The genome of Brugia malayi - all worms are not created equal. Parasitol Int 58: 6-11.
36. Frank GR, Mondesire RR, Brandt KS, Wisnewski N, 1998. Antibody to the Dirofilaria immitis aspartyl protease inhibitor homologue is a diagnostic marker for feline heartworm infections. J Parasitol 84: 1231-1236. (Pubitemid 29036473)
37. Mejia JS, Nkenfou C, Southworth MW, Perler FB, Carlow CK, 1994. Expression of an Onchocerca volvulus Ov 33 homologue in Dirofilaria immitis : potential in immunodiagnosis of heartworm infection. Parasite Immunol 16: 297-303. (Pubitemid 24245576)
38. Krushna NS, Shiny C, Dharanya S, Sindhu A, Aishwarya S, Narayanan RB, 2009. Immunolocalization and serum antibody responses to Brugia malayi pepsin inhibitor homolog (Bm-33). Microbiol Immunol 53: 173-183.
39. Hussein O, El Setouhy M, Ahmed ES, Kandil AM, Ramzy RM, Helmy H, Weil GJ, 2004. Duplex Doppler sonographic assessment of the effects of diethylcarbamazine and albendazole therapy on adult filarial worms and adjacent host tissues in Bancroftian filariasis. Am J Trop Med Hyg 71: 471-477. (Pubitemid 39458341)
40. Tremoulet AH, Avila-Aguero ML, Paris MM, Canas-Coto A, Ulloa-Gutierrez R, Faingezicht I, 2004. Albendazole therapy for Microsporidium diarrhea in immunocompetent Costa Rican children. Pediatr Infect Dis J 23: 915-918. (Pubitemid 40812777)
41. Fournier S, Liguory O, Sarfati C, David-Ouaknine F, Derouin F, Decazes JM, Molina JM, 2000. Disseminated infection due to Encephalitozoon cuniculi in a patient with AIDS: case report and review. HIV Med 1: 155-161.
42. Didier ES, Maddry JA, Brindley PJ, Stovall ME, Didier PJ, 2005. Therapeutic strategies for human microsporidia infections. Expert Rev Anti Infect Ther 3: 419-434. (Pubitemid 40872536)
43. Stanisic DI, Richards JS, McCallum FJ, Michon P, King CL, Schoepflin S, Gilson PR, Murphy VJ, Anders RF, Mueller I, Beeson JG, 2009. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Infect Immun 77: 1165-1174.
44. Eisele TP, Keating J, Bennett A, Londono B, Johnson D, Lafontant C, Krogstad DJ, 2007. Prevalence of Plasmodium falciparum infection in rainy season, Artibonite Valley, Haiti, 2006. Emerg Infect Dis 13: 1494-1496. (Pubitemid 350006982)
45. Punkosdy GA, Addiss DG, Lammie PJ, 2003. Characterization of antibody responses to Wolbachia surface protein in humans with lymphatic filariasis. Infect Immun 71: 5104-5114. (Pubitemid 37070753)